Mice lacking FXR expression in the intestine withstand diet-induced obesity (DIO), insulin resistance and non-alcoholic fatty liver disease, and several studies associated FXR with sensitivity to metabolic diseases [149,159,160,161,162]. Here, NR1H4 is linked to metabolic dysfunction-associated steatotic liver disease.